Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:2576-2581
Published online before print September 16, 2004, doi: 10.1161/01.STR.0000143450.04438.ae
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/11/2576    most recent
01.STR.0000143450.04438.aev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosenzweig, H. L.
Right arrow Articles by Stenzel-Poore, M. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosenzweig, H. L.
Right arrow Articles by Stenzel-Poore, M. P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Ischemic biology - basic studies

(Stroke. 2004;35:2576.)
© 2004 American Heart Association, Inc.


Original Contributions

Endotoxin Preconditioning Prevents Cellular Inflammatory Response During Ischemic Neuroprotection in Mice

Holly L. Rosenzweig, BA; Nikola S. Lessov, MD; David C. Henshall, PhD; Manabu Minami, MD PhD; Roger P. Simon, MD Mary P. Stenzel-Poore, PhD

From the Department of Molecular Microbiology and Immunology (H.L.R., M.P.S.-P.) and the Oregon Stroke Center (N.S.L.), Oregon Health and Science University, Portland; and Robert S. Dow Neurobiology Laboratories (D.C.H., M.M., R.P.S.), Legacy Research, Portland, Ore.

Correspondence to Dr Mary P. Stenzel-Poore, Department of Molecular Microbiology and Immunology, L220, Oregon Health and Science University, 3181 SW Sam Jackson Park Rd, Portland, OR 97239. E-mail poorem{at}ohsu.edu

Background and Purpose— Tolerance to ischemic brain injury is induced by several preconditioning stimuli, including lipopolysaccharide (LPS). A small dose of LPS given systemically confers ischemic protection in the brain, a process that appears to involve activation of an inflammatory response before ischemia. We postulated that LPS preconditioning modulates the cellular inflammatory response after cerebral ischemia, resulting in neuroprotection.

Methods— Mice were treated with LPS (0.2 mg/kg) 48 hours before ischemia induced by transient middle cerebral artery occlusion (MCAO). The infarct was measured by 2,3,5-triphenyltetrazolium chloride staining. Microglia/macrophage responses after MCAO were assessed by immunofluorescence and flow cytometry. The effect of MCAO on white blood cells in the brain and peripheral circulation was measured by flow cytometry 48 hours after MCAO.

Results— LPS preconditioning induced significant neuroprotection against MCAO. Administration of low-dose LPS before MCAO prevented the cellular inflammatory response in the brain and blood. Specifically, LPS preconditioning suppressed neutrophil infiltration into the brain and microglia/macrophage activation in the ischemic hemisphere, which was paralleled by suppressed monocyte activation in the peripheral blood.

Conclusions— LPS preconditioning induces neuroprotection against ischemic brain injury in a mouse model of stroke. LPS preconditioning suppresses the cellular inflammatory response to ischemia in the brain and circulation. Diminished activation of cellular inflammatory responses that ordinarily exacerbate ischemic injury may contribute to neuroprotection induced by LPS preconditioning.


Key Words: cerebral ischemia, focal • inflammation • leukocytes • mice • microglia




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
T. P. Obrenovitch
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Physiol Rev, January 1, 2008; 88(1): 211 - 247.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. J. Hickey, X. You, V. Kaimaktchiev, M. Stenzel-Poore, and R. M. Ungerleider
Lipopolysaccharide preconditioning induces robust protection against brain injury resulting from deep hypothermic circulatory arrest
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1588 - 1596.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Chamorro, X. Urra, and A. M. Planas
Infection After Acute Ischemic Stroke: A Manifestation of Brain-Induced Immunodepression
Stroke, March 1, 2007; 38(3): 1097 - 1103.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. P. Stenzel-Poore, S. L. Stevens, J. S. King, and R. P. Simon
Preconditioning Reprograms the Response to Ischemic Injury and Primes the Emergence of Unique Endogenous Neuroprotective Phenotypes: A Speculative Synthesis
Stroke, February 1, 2007; 38(2): 680 - 685.
[Abstract] [Full Text] [PDF]